UNSPSC 41181561: Systemic lupus erythematosus immunological test system

In this classification, a Systemic lupus erythematosus immunological test system is a device that consists of the reagents used to identify by immunochemical techniques Systemic lupus erythematosus. US FDA regulates Systemic lupus erythematosus immunological test system under 21 CFR 866.5820 and under FDA product code DHC.

UNSPSC 41181561 Systemic lupus erythematosus immunological test system is a Commodity code that shows minimal alignment with the code's nominal scope in recent state and local procurement activity. The recent opportunities posted under this code encompass precision optical and electrical testing equipment, laboratory software platforms, water quality and environmental monitoring instruments, and university research apparatus—none of which are immunological test systems or lupus-related diagnostics. The issuing bodies represent a mix of municipal utilities (Lee County Port Authority, City of Tampa, City of Phoenix, Kissimmee Utility Authority), regional universities (Jackson State University, Texas State University, Texas A&M University System, Valencia College), county governments (Collier County, Marion County), state health agencies (Texas Department of State Health Services), and specialized authorities (Colorado State Patrol, Lubbock Power & Light). No repeat buyers appear in the block.

Recent solicitations posted under this code include the City of Ocala Electric Utility's RFP for a Three-Phase Meter Test Board system (RFP #ELE/260570, due April 30, 2026), Lee County Port Authority's e-quote for airfield photometric testing at Southwest Florida International Airport (solicitation 2026115BW, due October 29, 2026), Jackson State University's sole-source purchase of Schrodinger Small Molecule Drug Discovery Suite software (RFX 3150007041, objections due October 13, 2026), and Texas Health and Human Services Commission's IFB for laboratory equipment repair and maintenance services covering sterilization equipment (HHS0017421V2, due August 26, 2026). Geographic activity is concentrated in Florida (Tampa, Ocala, Lee County, Collier County, Orlando), with secondary activity in Texas (Jackson State, Texas A&M, Lubbock, Harlingen), Colorado, Oregon, Arizona, and Ohio. The code's recent activity suggests a data-tagging mismatch rather than material procurement interest in immunological diagnostics.